Menu
Not yet recruiting NCT07601061

Simplifying Diet Tracking in a Digital Weight Loss Intervention

No phase Interventional Overweight Obesity Weight Loss Health Behavior

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Simplified Dietary Self-Monitoring, Detailed Dietary Self-Monitoring, Core Behavioral Weight Loss Intervention.
Who it may be relevant to
Registry conditions: Overweight, Obesity, Weight Loss, Health Behavior. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Simplifying Dietary Self-Monitoring in a Digital Weight Loss Intervention

Overview

The purpose of this study is to compare two approaches for tracking dietary intake in a 12-month fully digital weight loss intervention: (1) Simplified approach: track Red Zone Foods (e.g., foods high in calories and low in nutritional value) vs. (2) Detailed approach: track all foods and their corresponding calories. In essence, this is a head-to-head comparison of two tracking approaches; the investigators are evaluating whether weight loss is comparable over 12 months, or whether one approach will have greater weight loss. The investigators will recruit 328 adults. Broadly, adults with overweight or obesity who live in the United States will be eligible. The weight loss intervention will last 12 months. All participants will be asked to track their dietary intake + body weight + steps daily as well as complete weekly behavioral lessons and action plans to promote healthy eating and physical activity. All study tasks will occur remotely. Assessment of body weight and survey measures will occur at the beginning of the trial ("baseline"), and at 1, 6, 12, and 18 months.

Interventions

  • Behavioral Simplified Dietary Self-Monitoring
    Participants randomized to receive this intervention are instructed to track their Red Zone Foods (i.e., foods high in calories and low in nutritional value) daily via a web-based checklist. Participants receive a daily Red Zone Food goal.
  • Behavioral Detailed Dietary Self-Monitoring
    Participants randomized to receive this intervention are instructed to track all foods/drinks and their corresponding calories daily via a mobile app. Participants receive a daily calorie goal.
  • Behavioral Core Behavioral Weight Loss Intervention
    All participants receive a 12-month core behavioral weight loss intervention consisting of the following: goal setting; daily self-monitoring of body weight \& steps; weekly behavioral lessons and action plans to promote healthy eating and physical activity; and tailored feedback. The intervention will be delivered remotely via email and/or text message.

Primary outcome measures

  • Weight Change from Baseline to 12 Months [Time frame: Baseline, 12 Months]
Secondary outcome measures (11)
  • Weight Change from Baseline to 1 Month [Time frame: Baseline, 1 Month]
  • Weight Change from Baseline to 6 Months [Time frame: Baseline, 6 Months]
  • Weight Change from Baseline to 18 Months [Time frame: Baseline, 18 Months]
  • Caloric Intake Change from Baseline to 12 Months [Time frame: Baseline, 12 Months]
  • Diet Quality Change from Baseline to 12 Months [Time frame: Baseline, 12 Months]
  • Step Count Change from Baseline to 12 Months [Time frame: Baseline, 12 Months]
  • Health-Related Quality of Life (Physical Health) Change from Baseline to 12 Months [Time frame: Baseline, 12 Months]
  • Health-Related Quality of Life (Mental Health) Change from Baseline to 12 Months [Time frame: Baseline, 12 Months]
  • Engagement in Self-Monitoring Dietary Intake [Time frame: daily during the 12-month intervention]
  • Engagement in Self-Monitoring Weight [Time frame: daily during the 12-month intervention]
  • Engagement in Self-Monitoring Steps [Time frame: daily during the 12-month intervention]

Eligibility criteria

Inclusion criteria

  • adults (ages 18+ years)
  • body mass index (BMI) 25.0 to 45.0 kg/m\^2
  • smartphone ownership
  • willing to install a mobile app on personal smartphone
  • access to a personal email account
  • English or Spanish language proficiency
  • interest in losing weight through behavioral strategies
  • living in the United States
  • willing to be randomized

Exclusion criteria

  • concurrent enrollment in another weight management intervention
  • loss of ≥5% weight in the past 6 months
  • prior or planned bariatric surgery during the trial period
  • current or planned pregnancy during the trial period, or recent pregnancy in the past 6 months
  • currently breastfeeding or lactating
  • current use of anti-obesity medications
  • living with someone else participating in the study
  • hospitalization for a mental health condition in the past 12 months
  • inability to engage in moderate forms of physical activity akin to brisk walking
  • medical or psychiatric contraindication (e.g., end stage renal disease, cancer, schizophrenia, dementia, use of steroids, use of antipsychotic medication)
  • if an individual would be better suited for a more intensive or different type of intervention based on a health condition (e.g., individuals with history of an eating disorder or cardiovascular event, uncontrolled hypertension, or uncontrolled diabetes mellitus)
  • investigator discretion for safety reasons

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Stanford University School of Medicine — Palo Alto

Identifiers

NCT: NCT07601061 · 87051

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗